GLP-1 agonist drugs essentially mimic the hormone’s action. Quite a few have been developed, including semaglutide, ...

Diabetes and weight loss drug semaglutide has been trialled in people with Alzheimer's. We explain what it means for dementia ...

The singer and actress has lost more than 60Ibs through a combination of regular exercise, dietary tweaks and low doses of ...

Novo Nordisk (NVO) remains a strong buy in the weight loss/diabetes market despite challenges. Read here for an investment ...

THERE is a long list of things that might give you a cough at this time of year – and a new discovery has made a surprising ...

The fight against obesity is one of the major challenges of 21st century medicine. This chronic disease, with its numerous ...

"Many people are on these medications before pregnancy and are benefiting tremendously, [but] clinicians following these ...

The Food and Drug Administration is set to treat the application under its priority program to accelerate the review of ...

The weight-loss drug eloralintide shows up to 20% body weight reduction in trial, offering hope for obesity treatment beyond ...

Eli Lilly and Novo Nordisk have announced they are working on new oral drugs that can be used for type-2 diabetes and weight ...

The next-generation “GLP-1 plus” drugs will be tailored to the health needs of individual patients. “ Ozempic is about to be ...

Eli Lilly announced trial results for its weight-loss medication, orforglipron, in August. Orforglipron is a once-daily oral ...